Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Millendo Therapeutics Inc (MLND)

Millendo Therapeutics Inc (MLND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Millendo Therapeutics Inc. is a biopharmaceutical company. It focuses on developing novel treatments for orphan endocrine diseases. The company's product candidate consists of AZP-531 and ATR-101 which are in clinical stage. Millendo Therapeutics Inc., formerly known as OvaScience Inc., is based in Ann Arbor, United States.

Income Statement

(Values in U.S. Thousands) Mar, 2021 Dec, 2020 Sep, 2020 Jun, 2020 Mar, 2020
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -8,390 -7,360 -6,370 -10,670 -12,000
Net Income Growth -13.99% -15.54% +40.30% +11.08% +5.51%

Balance Sheet

(Values in U.S. Thousands) Mar, 2021 Dec, 2020 Sep, 2020 Jun, 2020 Mar, 2020
Total Assets 31,710 43,410 48,840 57,130 68,050
Total Assets Growth -26.95% -11.12% -14.51% -16.05% -9.23%
Total Liabilities 6,080 9,680 9,020 12,190 13,410
Total Liabilities Growth -37.19% +7.32% -26.00% -9.10% -11.19%

Cash Flow

(Values in U.S. Thousands) Mar, 2021 Dec, 2020 Sep, 2020 Jun, 2020 Mar, 2020
Operating Cash Flow -11,840 -30,440 -25,130 -18,030 -10,160
Operating Cash Flow Growth +61.10% -21.13% -39.38% -77.46% +75.35%
Net Cash Flow -11,810 -24,850 -19,760 -12,500 -4,640
Change in Net Cash Flow +52.47% -25.76% -58.08% -169.40% +54.78%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot